Document is current
Any future updates will be listed below
-
Authors
Dickstein, Daniel R. https://orcid.org/0000-0003-4606-5574
Edwards, Collin R.
Lehrer, Eric J.
Tarras, Elizabeth S.
Gallitto, Matthew
Sfakianos, John
Galsky, Matthew D. https://orcid.org/0000-0001-7655-9378
Stock, Richard
Safer, Joshua D. https://orcid.org/0000-0003-2497-8401
Rosser, B. R. Simon
Marshall, Deborah C. https://orcid.org/0000-0002-6675-7482
- License Information
-
More Information
Article History
Accepted: 3 May 2023
First Online: 22 May 2023
Competing interests
: M.D.G. declares research funding from Bristol Myers Squibb, Novartis, Dendreon, AstraZeneca, Merck and Genentech and is a paid advisory board consultant for Bristol Myers Squibb, Merck, Genentech, AstraZeneca, Pfizer, EMD Serono, SeaGen, Janssen, Numab, Dragonfly, GlaxoSmithKline, Basilea, UroGen, Rappta Therapeutics, Alligator, Silverback, Fujifilm and Curis. The other authors declare no competing interests.
